#AskDrDurie: Will any of the newly FDA-approved drugs be available for frontline therapy?
In this week's video, Dr. Brian G.M. Durie discusses if the newly FDA-approved drugs (Ninlaro, Empliciti, Darzalex) be available for frontline therapy?
When to use the new drugs requires a case-by-case discussion, with possible use in early disease stages.
Dr. Brian G.M. Durie serves as Chairman of the International Myeloma Foundation and serves on its Scientific Advisory Board. Additionally, he is Chairman of the IMF's International Myeloma Working Group, a consortium of nearly 200 myeloma experts from around the world. Dr. Durie also leads the IMF’s Black Swan Research Initiative®.